Veterinary Medicines

Bioestrovet 0.250 mg/ml solution for injection for cattle

Authorised
  • Cloprostenol sodium
Download as PDF

Product identification

Medicine name:
Bioestrovet 0.250 mg/ml solution for injection for cattle
Estrovet 0,250 mg/ml Roztwór do wstrzykiwań
Active substance:
  • Cloprostenol sodium
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Cloprostenol sodium
    0.26
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        1
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • Type 1 (colourless) glass vial closed with bromobutyl rubber stopper coated with a FluroTec film (ETFE) and a polypropyleneflip-off cap.Pack size:Box with 1 vial of 20 ml
  • Type 1 (colourless) glass vial closed with bromobutyl rubber stopper coated with a FluroTec film (ETFE) and a polypropyleneflip-off cap.Pack size:Box with 1 vial of 50 ml
  • Type 1 (colourless) glass vial closed with bromobutyl rubber stopper coated with a FluroTec film (ETFE) and a polypropyleneflip-off cap.Pack size:Box with 1 vial of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2683
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0359/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Polish (PDF)
Published on: 6/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 6/02/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 6/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."